e-learning
resources
Virtual 2020
Pre-Congress Content
News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of Octreotide in patients with refractory Chronic Cough
A. Morice (Cottingham, United Kingdom), A. Loonat (Cottingham, United Kingdom), C. Wright (Cottingham, United Kingdom)
Source:
Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Session:
News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Session type:
E-poster session
Number:
1287
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Morice (Cottingham, United Kingdom), A. Loonat (Cottingham, United Kingdom), C. Wright (Cottingham, United Kingdom). The effect of Octreotide in patients with refractory Chronic Cough. 1287
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
A 41-year-old male with cough productive of yellow sputum and worsening breathlessness
Related content which might interest you:
Chronic refractory cough
Source: Virtual Congress 2020 – Clinical grand round: revisiting current guidelines
Year: 2020
The Efficacy of Bradanicline in Refractory Chronic Cough
Source: Virtual Congress 2020 – Chronic cough: only symptom or disease?
Year: 2020
Chronic cough diagnosis and treatment
Source: International Congress 2017 – ME4 Chronic cough - FULLY BOOKED
Year: 2017
Chronic inhaled corticosteroids in patients with bronchiectasis who suffer an exacerbation
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Response of chronic cough to acid suppresive therapy in patients with gastroesophageal reflux disease
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013
Response to subcutaneous octreotide in a cohort of patients with bronchorrhoea
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Successful Management of Chronic Cough
Source: ERS Live 2007
Year: 2007
Chronic cough
Source: Breathe 2014; 10:349-352
Year: 2014
Treatment of chronic cough with morphine
Source: Eur Respir J 2006; 28: Suppl. 50, 437s
Year: 2006
Capsaicin sensitivity in patients with chronic refractory unexplained cough
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011
Medication Effect on Acute Exacerbation and Mortality in Patients with Coexistent COPD and GERD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Symptoms of autonomic dysfunction in chronic cough patients
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Management of refractory dyspnoea in COPD
Source: Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening
Year: 2021
Microbiome Use to Stratify Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (MUSIC) trial: baseline data and impact of inhaled corticosteroid withdrawal in severe COPD with frequent exacerbations
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020
Evaluation of nasal optiflow device in management of COPD patients in acute exacerbations
Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning
Year: 2015
Efficacy and response predictors of inhaled corticosteroid treatment on chronic cough
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
Opioids for chronic refractory breathlessness: patient predictors of beneficial response
Source: Eur Respir J 2013; 42: 758-766
Year: 2013
Opiate therapy in chronic cough
Source: Eur Respir J 2005; 26: Suppl. 49, 129s
Year: 2005
Chronic cough in COPD
Source: Annual Congress 2003 - New pathophysiological aspects in COPD
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept